HCAT

Health Catalyst, Inc. is a provider of data and analytics technology and services to healthcare organizations. The Company's solution comprises its cloud-based data platform, applications, and expertise. Its segments include Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and earns primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally a combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its clients to fully configure and utilize the benefits of its technology offerings. Its clients, which are primarily healthcare providers, use its Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements.

Wall Street analysts forecast HCAT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HCAT is 4.00 USD with a low forecast of 3.00 USD and a high forecast of 5.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Health Catalyst Inc revenue for the last quarter amounts to 76.32M USD, decreased -0.04 % YoY.

Health Catalyst Inc. EPS for the last quarter amounts to -0.32 USD, increased 33.33 % YoY.

Health Catalyst Inc (HCAT) has 1300 emplpoyees as of December 17 2025.

Today HCAT has the market capitalization of 172.23M USD.